| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |